A study on male contraception carried out by the University of Edinburgh and published in The Journal of Clinical Endocrinology & Metabolism, had to be interrupted at the end of October. A certain number of men complained of multiple side effects: mood swings, muscle pain, acne or increased libido.
During this study, 320 men between 18 and 45 years of age, were injected with two hormones: a progestogen, which reduces sperm production by decreasing testosterone levels and, at the same time, testosterone, to limit the side effects of progestogen and maintain secondary male sexual characteristics.
Mario Philip Reyes Festin, a scientist with the World Health Organisation, explained that it would certainly be several years before the male contraceptive could be used for the purpose for which it is intended. He also voiced reservations regarding the total disappearance of side effects (see Male contraception for 2017?).
Au féminin (Violette Salle), 03/11/2016.